CVS Health reported $2.9 billion in fourth quarter net income as the company begins to get a handle on costs that have hit ...
The collaboration will place an emphasis on targeted populations living with hypertension in Illinois, Kentucky, Michigan and ...
CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.
CVS Health's workforce reduction follows a broader pattern of retrenchment across the health insurance sector. Horizon Blue ...
Aetna members in California can now access the MD-03 Protocol™ at lower monthly costs, making personalized skin health ...
Some payments that were originally expected in early 2026 instead arrived late in 2025, boosting reported 2025 cash flow but reducing 2026’s starting point. As a result, CVS now guides to at least $9 ...
Medications such as Wegovy and Zepbound will no longer be covered for weight loss, although GLP-1 drugs for diabetes will still be approved.
The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into the role in late 2024.
CVS Health’s rehabilitation efforts to return to full strength appear to be on track after a strong fourth quarter. The ...
Your doctor submits a claim to your health insurance. The claim is denied. You might be justified in thinking the denial is ...
CVS Health reaffirmed its guidance for full year 2026 revenue of at least $400 billion and adjusted EPS in the range of $7 to $7.20. Newman commented, "We are encouraged by the strength of our results ...
Democrat Elizabeth Warren and Republican Josh Hawley don't agree on much, but they've found common ground on health care and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results